Clinical Trial Update: Gene Therapy in Treating Children With Refractory or Recurrent Neuroblastoma [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial of a gene therapy for children with refractory or recurrent neuroblastoma has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroblastoma

Drugs mentioned

• Gene therapy agent (unspecified)

Snippet

Sponsor: St. Jude Children's Research Hospital | Conditions: Neuroblastoma | Phase 1 | Status: COMPLETED